Olopta 0.1% (Ophthalmic Solution)

Product Title

• Patadin Eye Drops
• Olopta Nasal Spray
• Olopta Tablet

Categories

• Medicine
• Health & Wellness
• Eye Care
• Nasal Care

Description

• Indicated for the treatment of signs and symptoms of allergic conjunctivitis
• Relief of symptoms of seasonal allergic rhinitis
• Treatment of allergic rhinitis and allergic skin conditions

Color Options

• Transparent
• White

Functions

• Relieves itchy, watery, red, and swollen eyes
• Relieves nasal symptoms of allergies
• Relieves allergy symptoms such as skin rashes, swelling, hives, itching, sneezing, runny or stuffy nose

Materials

• Olopatadine
• Olopatadine hydrochloride
• Benzalkonium Chloride
• Soft Contact Lenses

Technical Specifications

• 0.1%, 0.2%, 0.7% concentration for eye drops
• 5 mg tablet dosage
• Intranasal administration for nasal spray
• Protein binding of olopatadine at approximately 55% in human serum

Design Elements

• Bottle design for eye drops
• Nasal spray container design
• Tablet shape and size

Usability Features

• Contact lens compatibility
• Primed nasal spray for fine mist
• Convenient dosing schedule

Pharmacological Action

• Mast cell stabilization
• Histamine H1 receptor antagonist with high selectivity
• Inhibition of inflammatory mediators and cytokines release

Mode of Action

• Stabilizes rodent basophils and human conjunctival mast cells
• Antagonist at the histamine H1 receptors
• Blocks the H1 receptor signaling pathway

Pharmacokinetics

• Peak plasma concentrations observed between 30 minutes and 1 hour after intranasal administration
• Moderate protein binding of olopatadine at approximately 55% in human serum
• Plasma elimination half-life of olopatadine is 8 to 12 hours

Dosage Instructions

• Different concentrations for eye drops with specific dosing intervals
• Variety of dosages based on age and symptoms
• Guidelines for missed doses

Administration Instructions

• Step-by-step guide for using nasal spray
• Cleaning instructions for nasal spray
• Contact lens usage precautions

Interaction

• No formal drug-drug interaction studies conducted for Olopta Nasal Spray
• Predominant elimination by renal excretion

Contraindications

• Known hypersensitivity to any component of the product
• Allergy to Olopatadine 5 mg tablet

Side Effects

• Rarely reported headaches
• Adverse effects like asthenia, blurred vision, burning or stinging, dry eye, pharyngitis, pruritus, taste perversion

Pregnancy & Lactation

• Not teratogenic in rats and rabbits
• Caution advised in pregnant women and nursing mothers

Precautions & Warnings

• Advice against wearing contact lenses if the eye is red
• Patient instructions for using nasal spray and tablets
• Consultation before stopping the medicine

Use in Special Populations

• No overall differences in safety or effectiveness observed

Overdose Effects

• No specific information on Olopta overdose
• Warning on excessive use of medication

Therapeutic Class

• Ophthalmic Non-Steroid drugs

Storage Conditions

• Room temperature storage
• Protection from light
• One month shelf life after opening

Related Brands

• Alacot 0.1% (Ophthalmic Solution) - square-pharmaceuticals-plc
• Alacot DS 0.2% (Ophthalmic Solution) - square-pharmaceuticals-plc
• Aladay 0.1% (Ophthalmic Solution) - eskayef-pharmaceuticals-ltd
• Aladay DS 0.2% (Ophthalmic Solution) - eskayef-pharmaceuticals-ltd
• Alchek 0.1% (Ophthalmic Solution) - apex-pharmaceuticals-ltd